MD2068F1 - Method of treatment of the Herpes simplex infection - Google Patents

Method of treatment of the Herpes simplex infection

Info

Publication number
MD2068F1
MD2068F1 MD20010217A MD20010217A MD2068F1 MD 2068 F1 MD2068 F1 MD 2068F1 MD 20010217 A MD20010217 A MD 20010217A MD 20010217 A MD20010217 A MD 20010217A MD 2068 F1 MD2068 F1 MD 2068F1
Authority
MD
Moldova
Prior art keywords
treatment
herpes simplex
simplex infection
infection
vitaminotherapy
Prior art date
Application number
MD20010217A
Other languages
Romanian (ro)
Other versions
MD2068G2 (en
Inventor
Constantin Spanu
Tiberiu Holban
Vasile Vutcariov
Petru Scoferta
Vladimir Valica
Mihai Magdei
Pavel Chintea
Raisa Popovici
Liudmila Birca
Igor Spanu
Original Assignee
Ct Nat Stiintifico Practic De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Nat Stiintifico Practic De filed Critical Ct Nat Stiintifico Practic De
Priority to MDA20010217A priority Critical patent/MD2068G2/en
Publication of MD2068F1 publication Critical patent/MD2068F1/en
Publication of MD2068G2 publication Critical patent/MD2068G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, namely to the infectious diseases. Summary of the invention consists in that for treatment of the Herpes simplex infection the patients are prescribed an etiological, anti-inflammatory, sedative, analgesic, topical treatment, immunomodulators and vitaminotherapy, as well as additionally within 15 days they are administered 2 times a day for 50 mg of pacovirin per os.Claims: 1
MDA20010217A 2001-07-10 2001-07-10 Method of treatment of the Herpes simplex infection MD2068G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20010217A MD2068G2 (en) 2001-07-10 2001-07-10 Method of treatment of the Herpes simplex infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20010217A MD2068G2 (en) 2001-07-10 2001-07-10 Method of treatment of the Herpes simplex infection

Publications (2)

Publication Number Publication Date
MD2068F1 true MD2068F1 (en) 2003-01-31
MD2068G2 MD2068G2 (en) 2003-06-30

Family

ID=19739894

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20010217A MD2068G2 (en) 2001-07-10 2001-07-10 Method of treatment of the Herpes simplex infection

Country Status (1)

Country Link
MD (1) MD2068G2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3724G2 (en) * 2008-03-07 2009-05-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Method for treating herpetic stomatitis of medium and severe degree
MD667Z (en) * 2013-03-20 2014-03-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for treatment of infectious mononucleosis in children

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1473G2 (en) * 1998-06-02 2001-05-31 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Antiherpetic remedy
MD1875G2 (en) * 1999-11-01 2002-09-30 Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова Method of treatment of the acute viral hepatitis B

Also Published As

Publication number Publication date
MD2068G2 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
WO2003097052A3 (en) Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
TW200500355A (en) Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
WO2003000343A3 (en) Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
CZ309247B6 (en) 40-O- (2-hydroxyethyl) rapamycin for use as the sole active ingredient in treating a solid tumour
PL376797A1 (en) Quinolinyl-pyrrolopyrazoles
HK1071310A1 (en) Combination therapy for the treatment of cancer
HK1068606A1 (en) Novel aminobenzoephenones
WO2004043378A3 (en) Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
ATE193442T1 (en) 3,4-DIARYL CHROMANES FOR THE TREATMENT OF DERMATITIS
PT1150704E (en) MELAGATRAN FOR THE TREATMENT OF INFLAMMATION
PE20031047A1 (en) TREATMENT OF POST-MENOPAUSAL PATIENTS IN PATIENTS WITH BREAST CANCER
MD2549F1 (en) Method of treatment of the chronic viral hepatitis C
MXPA05008843A (en) Therapeutic system comprising amoxicillin and clavulanic acid.
MD2068F1 (en) Method of treatment of the Herpes simplex infection
MXPA01012936A (en) Pharmaceutical composition containing sibutramine and orlistat.
HUP0402062A2 (en) Use of alkanoyl l-carnitine for the treatment of erectile dysfunction and pharmaceutical compositions containing them
AR109456A2 (en) USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPY
WO2004073627A3 (en) Novel therapeutic method and compositions for topical administration
AU2002236587A1 (en) Compositions for adhesion prevention
WO2001074364A3 (en) A use of galantamine for the treatment of alzheimer's disease; targeting the underlying cause of the disease
MD3446G2 (en) Method of HIV infection treatment
WO2003066806A3 (en) Therapeutic use of aziridino compounds
AU2450900A (en) Therapeutic nucleoside compound
MD1780G2 (en) Method of treatment of patients with hepatic cirrhosis
MD1609G2 (en) Method of the recidivating chronic aphthous stomatitis treatment

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees